HIV drug resistance

HIV drug resistance

Antiretroviral drug resistance AIDS The resistance of a strain of HIV to an agent–eg, a reverse transcriptase inhibitor, which occurs in 5%-20% of those newly infected with HIV
References in periodicals archive ?
To identify an effective drug regimen and thereby prevent the further development and spread of HIV drug resistance, resistance must be identified before ART is initiated.
HIV drug resistance testing was performed using an in-house protease/reverse transcriptase genotyping assay developed by FIOCRUZ, (14) which is certified by the National Institute of Allergy and Infectious Diseases virology quality assessment (NIAID-VQA).
Four children had suspected HIV drug resistance but confirmed in 2 (6.
We categorized information on epidemiology, key populations, treatment and care, antiretroviral therapy (ART) access, prevention of mother-to-child transmission of HIV, community viral suppression, and HIV drug resistance.
To address this threat, WHO is developing a Global Action Plan on HIV drug resistance - calling on countries to continue surveillance to ensure rapid action?
Request for proposal for Consultancy to support the data management for HIV drug resistance (2015/HTM/HIV/016)
Increases in paediatric HIV drug resistance in resource-limited settings have been driven by limited access to routine viral load monitoring, limited availability of paediatric drugs for second-line therapy and complexities related to PMTCT, paediatric care and ART adherence, as seen in the presented case.
Historically, data has shown the prevalence of HIV drug resistance varies with geographic location, year, and community ARV treatment exposure.
Presently, he is a member of the Scientific Committee of Stanford University School of Medicine Drug Resistance Database, California, USA, and a member of the Advisory Committee of the World Health Organization HIV Drug Resistance Network, Geneva, Switzerland.
The "WHO HIV Drug Resistance Report 2012" is available at www.
Without continued and increased national and international efforts, rising HIV drug resistance could jeopardise a decade-long trend of decreasing HIV/Aids-related illness and death in low- and middle-income countries," researchers Dr Silvia Bertagnolio from the WHO and Dr Ravindra Gupta at UCL wrote in the Lancet.